{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "3330561", "DateCompleted": {"Year": "1988", "Month": "07", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "12"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0386-846X", "JournalIssue": {"Volume": "10", "Issue": "12", "PubDate": {"Year": "1987", "Month": "Dec"}}, "Title": "Journal of pharmacobio-dynamics", "ISOAbbreviation": "J Pharmacobiodyn"}, "ArticleTitle": "Inhibition of mutagenicity by glycyrrhiza extract and glycyrrhizin.", "Pagination": {"StartPage": "685", "EndPage": "688", "MedlinePgn": "685-8"}, "Abstract": {"AbstractText": ["The effects of Glycyrrhiza extract and one of its components, glycyrrhizin, on the mutagenicities of several mutagens were investigated by means of a modification of the Ames' test. Both inhibited the mutagenicities of 3-amino-1,4-dimethyl-5 H-pyrido[4,3-b]-indole (Trp-P-1) and 3-amino-1-methyl-5 H-pyrido[4,3-b]indole. Since the Glycyrrhiza extract and glycyrrhizin inhibited the mutagenicity of activated Trp-P-1, it was clear that their inhibitory effects were not due to inhibition of the enzyme activity of the S9 fraction. Both Glycyrrhiza extract and glycyrrhizin also inhibited the mutagenicities of benzo[a]pyrene, 3-methylcholanthrene, 2-naphthylamine, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]-imidazole, dimethylnitrosoamine and dimethylaminoazobenzene. The mutagenicity of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2) was inhibited by the Glycyrrhiza extract but not by glycyrrhizin. This suggested that a component different from glycyrrhizin, present in the Glycyrrhiza extract, inhibited the mutagenicity of AF-2."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Science, Toho University, Chiba, Japan."}], "LastName": "Tanaka", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mano", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Akazai", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Narui", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kato", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Koyama", "ForeName": "Y", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Pharmacobiodyn", "NlmUniqueID": "7901854", "ISSNLinking": "0386-846X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "6FO62043WK", "NameOfSubstance": "Glycyrrhizic Acid"}, {"RegistryNumber": "P540XA09DR", "NameOfSubstance": "Glycyrrhetinic Acid"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["analogs & derivatives", "metabolism", "pharmacology"], "DescriptorName": "Glycyrrhetinic Acid"}, {"QualifierName": [], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Glycyrrhizic Acid"}, {"QualifierName": [], "DescriptorName": "Mutagenicity Tests"}, {"QualifierName": [], "DescriptorName": "Mutation"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Salmonella typhimurium"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1987", "Month": "12", "Day": "1"}, {"Year": "1987", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1987", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3330561", "10.1248/bpb1978.10.685"]}}]}